TRUE TEST 0.0065 MG — DIN 02271885
THIMEROSAL : 0.0065 MG DITHIOBIS (BENZOTHIAZOLE) : 0.02 MG ETHYLENEDIAMINE DIHYDROCHLORIDE : 0.041 MG POTASSIUM DICHROMATE : 0.019 MG BENZYL PARABEN : 0.16 MG ZINC DIETHYLDITHIOCARBAMATE : 0.068 MG N,N'-DIPHENYL-PARA-PHENYLENEDIAMINE : 0.025 MG N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE : 0.02 MG DIBUCAINE HYDROCHLORIDE : 0.073 MG CINNAMALDEHYDE : 0.034 MG PROPYLPARABEN : 0.16 MG DIPHENYLGUANIDINE : 0.068 MG EPOXY RESIN : 0.041 MG PERUVIAN BALSAM : 0.65 MG P-TERT-BUTYLPHENOL FORMALDEHYDE RESIN : 0.041 MG ROSIN : 0.69 MG NEOMYCIN SULFATE : 0.19 MG ISOEUGENOL : 0.015 MG ZINC DIBUTYLDITHIOCARBAMATE : 0.068 MG THIRAM : 0.005 MG AMYL CINNAMAL : 0.015 MG CINNAMYL ALCOHOL : 0.054 MG MERCAPTOBENZOTHIAZOLE : 0.061 MG OAK MOSS : 0.07 MG ETHYL PARABEN : 0.16 MG NICKEL SULFATE : 0.16 MG P-PHENYLENEDIAMINE : 0.073 MG N-CYCLOHEXYL-N'-PHENYL-PARA-PHENYLENEDIAMINE : 0.025 MG BENZOCAINE : 0.364 MG QUATERNIUM-15 : 0.081 MG EUGENOL : 0.034 MG N-HYDROXYMETHYLSUCCINIMIDE : 0.15 MG TETRACAINE HYDROCHLORIDE : 0.073 MG CHLOROQUINALDOL : 0.08 MG COBALTOUS CHLORIDE : 0.016 MG (MORPHOLINOTHIO)BENZOTHIAZOLE : 0.02 MG BUTYLPARABEN : 0.16 MG METHYLPARABEN : 0.16 MG GERANIOL : 0.07 MG HYDROXYCITRONELLAL : 0.054 MG BIS(1-PIPERIDYLTHIOCARBONYL)DISULFIDE : 0.005 MG DISULFIRAM : 0.005 MG WOOL ALCOHOLS : 0.81 MG METHYLCHLOROISOTHIAZOLINONE : 0.0032 MG N-ISOPROPYL-N'-PHENYL-PARA-PHENYLENEDIAMINE : 0.01 MG CLIOQUINOL : 0.08 MG TETRAMETHYLTHIURAM MONOSULFIDE : 0.005 MG · MEKOS LABORATORIES APS · PATCH · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is TRUE TEST?
TRUE TEST 0.0065 MG contains THIMEROSAL : 0.0065 MG DITHIOBIS (BENZOTHIAZOLE) : 0.02 MG ETHYLENEDIAMINE DIHYDROCHLORIDE : 0.041 MG POTASSIUM DICHROMATE : 0.019 MG BENZYL PARABEN : 0.16 MG ZINC DIETHYLDITHIOCARBAMATE : 0.068 MG N,N'-DIPHENYL-PARA-PHENYLENEDIAMINE : 0.025 MG N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE : 0.02 MG DIBUCAINE HYDROCHLORIDE : 0.073 MG CINNAMALDEHYDE : 0.034 MG PROPYLPARABEN : 0.16 MG DIPHENYLGUANIDINE : 0.068 MG EPOXY RESIN : 0.041 MG PERUVIAN BALSAM : 0.65 MG P-TERT-BUTYLPHENOL FORMALDEHYDE RESIN : 0.041 MG ROSIN : 0.69 MG NEOMYCIN SULFATE : 0.19 MG ISOEUGENOL : 0.015 MG ZINC DIBUTYLDITHIOCARBAMATE : 0.068 MG THIRAM : 0.005 MG AMYL CINNAMAL : 0.015 MG CINNAMYL ALCOHOL : 0.054 MG MERCAPTOBENZOTHIAZOLE : 0.061 MG OAK MOSS : 0.07 MG ETHYL PARABEN : 0.16 MG NICKEL SULFATE : 0.16 MG P-PHENYLENEDIAMINE : 0.073 MG N-CYCLOHEXYL-N'-PHENYL-PARA-PHENYLENEDIAMINE : 0.025 MG BENZOCAINE : 0.364 MG QUATERNIUM-15 : 0.081 MG EUGENOL : 0.034 MG N-HYDROXYMETHYLSUCCINIMIDE : 0.15 MG TETRACAINE HYDROCHLORIDE : 0.073 MG CHLOROQUINALDOL : 0.08 MG COBALTOUS CHLORIDE : 0.016 MG (MORPHOLINOTHIO)BENZOTHIAZOLE : 0.02 MG BUTYLPARABEN : 0.16 MG METHYLPARABEN : 0.16 MG GERANIOL : 0.07 MG HYDROXYCITRONELLAL : 0.054 MG BIS(1-PIPERIDYLTHIOCARBONYL)DISULFIDE : 0.005 MG DISULFIRAM : 0.005 MG WOOL ALCOHOLS : 0.81 MG METHYLCHLOROISOTHIAZOLINONE : 0.0032 MG N-ISOPROPYL-N'-PHENYL-PARA-PHENYLENEDIAMINE : 0.01 MG CLIOQUINOL : 0.08 MG TETRAMETHYLTHIURAM MONOSULFIDE : 0.005 MG. It is listed in the Health Canada Drug Product Database under DIN 02271885, held by MEKOS LABORATORIES APS, supplied as PATCH for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Jan-2013. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Tests For Allergic Diseases in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
5 holders have a Canadian DIN containing Tests For Allergic Diseases, across 10 DINs, of which 8 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| DORMER LABORATORIES INC. | 4 | 4 | TOPICAL HAPTEN GEL, TOPICAL HAPTEN LIQUID | Sourceable in Canada |
| ALK-ABELLO INC | 2 | 2 | HISTATROL | Sourceable in Canada |
| JUBILANT HOLLISTERSTIER LLC | 2 | 2 | NEGATIVE SKIN TEST CONTROL - GLYCERIN, POSITIVE SKIN TEST CONTROL-HISTAMINE | Sourceable in Canada |
| ALLERGY CANADA LTD | 1 | 0 | ALLERGY CANADA ALLERGEN EXTRACT - DIAGNOSTIC | No marketed DIN |
| MEKOS LABORATORIES APS | 1 | 0 | TRUE TEST | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.0065 MG |
|---|---|
| Dosage form | PATCH |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Tests For Allergic Diseases |
|---|---|
| ATC code | V04CL |
| AHFS class | 28:24.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02271885 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2271885 |
| Brand name | TRUE TEST |
| Generic / active ingredient | THIMEROSAL : 0.0065 MG DITHIOBIS (BENZOTHIAZOLE) : 0.02 MG ETHYLENEDIAMINE DIHYDROCHLORIDE : 0.041 MG POTASSIUM DICHROMATE : 0.019 MG BENZYL PARABEN : 0.16 MG ZINC DIETHYLDITHIOCARBAMATE : 0.068 MG N,N'-DIPHENYL-PARA-PHENYLENEDIAMINE : 0.025 MG N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE : 0.02 MG DIBUCAINE HYDROCHLORIDE : 0.073 MG CINNAMALDEHYDE : 0.034 MG PROPYLPARABEN : 0.16 MG DIPHENYLGUANIDINE : 0.068 MG EPOXY RESIN : 0.041 MG PERUVIAN BALSAM : 0.65 MG P-TERT-BUTYLPHENOL FORMALDEHYDE RESIN : 0.041 MG ROSIN : 0.69 MG NEOMYCIN SULFATE : 0.19 MG ISOEUGENOL : 0.015 MG ZINC DIBUTYLDITHIOCARBAMATE : 0.068 MG THIRAM : 0.005 MG AMYL CINNAMAL : 0.015 MG CINNAMYL ALCOHOL : 0.054 MG MERCAPTOBENZOTHIAZOLE : 0.061 MG OAK MOSS : 0.07 MG ETHYL PARABEN : 0.16 MG NICKEL SULFATE : 0.16 MG P-PHENYLENEDIAMINE : 0.073 MG N-CYCLOHEXYL-N'-PHENYL-PARA-PHENYLENEDIAMINE : 0.025 MG BENZOCAINE : 0.364 MG QUATERNIUM-15 : 0.081 MG EUGENOL : 0.034 MG N-HYDROXYMETHYLSUCCINIMIDE : 0.15 MG TETRACAINE HYDROCHLORIDE : 0.073 MG CHLOROQUINALDOL : 0.08 MG COBALTOUS CHLORIDE : 0.016 MG (MORPHOLINOTHIO)BENZOTHIAZOLE : 0.02 MG BUTYLPARABEN : 0.16 MG METHYLPARABEN : 0.16 MG GERANIOL : 0.07 MG HYDROXYCITRONELLAL : 0.054 MG BIS(1-PIPERIDYLTHIOCARBONYL)DISULFIDE : 0.005 MG DISULFIRAM : 0.005 MG WOOL ALCOHOLS : 0.81 MG METHYLCHLOROISOTHIAZOLINONE : 0.0032 MG N-ISOPROPYL-N'-PHENYL-PARA-PHENYLENEDIAMINE : 0.01 MG CLIOQUINOL : 0.08 MG TETRAMETHYLTHIURAM MONOSULFIDE : 0.005 MG |
| Market authorization holder | MEKOS LABORATORIES APS |
| Health Canada schedule | Schedule D |
| ATC code | V04CL |
| ATC anatomical main group | V — Various |
| ATC therapeutic subgroup | V04CL |
| Current status | CANCELLED POST MARKET |
| Status date | 10-Jan-2013 |
| Original market date | 2005-11-11 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
8 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| HISTATROL | 0.275 MG | SOLUTION | ALK-ABELLO INC | MARKETED | 00609706 |
| HISTATROL | 2.75 MG | SOLUTION | ALK-ABELLO INC | MARKETED | 00609692 |
| NEGATIVE SKIN TEST CONTROL - GLYCERIN | 50 % | LIQUID | JUBILANT HOLLISTERSTIER LLC | MARKETED | 02426773 |
| POSITIVE SKIN TEST CONTROL-HISTAMINE | 6 MG | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | 02439514 |
| TOPICAL HAPTEN GEL | 50 % | GEL | DORMER LABORATORIES INC. | MARKETED | 02466325 |
| TOPICAL HAPTEN GEL | 100 % | GEL | DORMER LABORATORIES INC. | MARKETED | 02466333 |
| TOPICAL HAPTEN LIQUID | 20 % | LIQUID | DORMER LABORATORIES INC. | MARKETED | 02466341 |
| TOPICAL HAPTEN LIQUID | 100 % | LIQUID | DORMER LABORATORIES INC. | MARKETED | 02466368 |
| ALLERGY CANADA ALLERGEN EXTRACT - DIAGNOSTIC | 0 UNIT | SOLUTION | ALLERGY CANADA LTD | DORMANT | 02242717 |
2 · Same class — other molecules in ATC V04CL
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Tests For Allergic Diseases | ALLERGY CANADA ALLERGEN EXTRACT - DIAGNOSTIC · HISTATROL · NEGATIVE SKIN TEST CONTROL - GLYCERIN · POSITIVE SKIN TEST CONTROL-HISTAMINE · +3 more | 10 | 8 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC V04C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| V04CX | Indocyanine Green · Other Diagnostic Agents | 59 | 16 |
| V04CC | Sincalide | 3 | 2 |
| V04CF | Tuberculin | 5 | 1 |
| V04CG | Histamine · Methylthionine · Pentagastrin | 5 | 1 |
| V04CD | Tests For Pituitary Function | 1 | 1 |
| V04C | Other Diagnostic Agents | 1 | 0 |
| V04CH | Aminohippuric Acid · Indigo Carmine | 2 | 0 |
| V04CJ | Protirelin | 3 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.